Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes

被引:33
作者
Varemo, Leif [1 ]
Henriksen, Tora Ida [2 ,3 ]
Scheele, Camilla [2 ,3 ,4 ]
Broholm, Christa [2 ,3 ]
Pedersen, Maria [2 ,3 ]
Uhlen, Mathias [5 ,6 ]
Pedersen, Bente Klarlund [2 ,3 ]
Nielsen, Jens [1 ,6 ]
机构
[1] Chalmers Univ Technol, Dept Biol & Biol Engn, S-41296 Gothenburg, Sweden
[2] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, DK-2100 Copenhagen O, Denmark
[3] Univ Copenhagen, Rigshosp, Ctr Phys Act Res, DK-2100 Copenhagen O, Denmark
[4] Univ Copenhagen, Ctr Basic Metab Res, Novo Nordisk Fdn, DK-2200 Copenhagen N, Denmark
[5] AlbaNova Univ Ctr, Royal Inst Technol KTH, Sch Biotechnol, Dept Prote, S-10691 Stockholm, Sweden
[6] Royal Inst Technol KTH, Sci Life Lab, S-17121 Stockholm, Sweden
来源
GENOME MEDICINE | 2017年 / 9卷
基金
新加坡国家研究基金会;
关键词
Type; 2; diabetes; Obesity; Skeletal myocytes; RNA-seq; Gene expression; Gene-set analysis; Metabolic network; DIFFERENTIAL EXPRESSION ANALYSIS; HUMAN SKELETAL-MUSCLE; EXTRACELLULAR-MATRIX; INSULIN SENSITIVITY; METABOLIC SYNDROME; DEVELOPMENTAL REGULATORS; GENE-EXPRESSION; RESISTANCE; DEFECTS; NETWORK;
D O I
10.1186/s13073-017-0432-2
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Skeletal muscle is one of the primary tissues involved in the development of type 2 diabetes (T2D). The close association between obesity and T2D makes it difficult to isolate specific effects attributed to the disease alone. Therefore, here we set out to identify and characterize intrinsic properties of myocytes, associated independently with T2D or obesity. Methods: We generated and analyzed RNA-seq data from primary differentiated myotubes from 24 human subjects, using a factorial design (healthy/T2D and non-obese/obese), to determine the influence of each specific factor on genome-wide transcription. This setup enabled us to identify intrinsic properties, originating from muscle precursor cells and retained in the corresponding myocytes. Bioinformatic and statistical methods, including differential expression analysis, gene-set analysis, and metabolic network analysis, were used to characterize the different myocytes. Results: We found that the transcriptional program associated with obesity alone was strikingly similar to that induced specifically by T2D. We identified a candidate epigenetic mechanism, H3K27me3 histone methylation, mediating these transcriptional signatures. T2D and obesity were independently associated with dysregulated myogenesis, down-regulated muscle function, and up-regulation of inflammation and extracellular matrix components. Metabolic network analysis identified that in T2D but not obesity a specific metabolite subnetwork involved in sphingolipid metabolism was transcriptionally regulated. Conclusions: Our findings identify inherent characteristics in myocytes, as a memory of the in vivo phenotype, without the influence from a diabetic or obese extracellular environment, highlighting their importance in the development of T2D.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Obesity and type 2 diabetes (Update 2023)
    Clodi, Martin
    Toplak, Hermann
    Resl, Michael
    Brix, Johanna
    Leitner, Deborah Raphaela
    Harreiter, Juergen
    Hoppichler, Friedrich
    Wascher, Thomas C.
    Schindler, Karin
    Ludvik, Bernhard
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (SUPPL 1) : 91 - 97
  • [42] The duration of obesity and the risk of type 2 diabetes
    Abdullah, Asnawi
    Stoelwinder, Johannes
    Shortreed, Susan
    Wolfe, Rory
    Stevenson, Christopher
    Walls, Helen
    de Courten, Maximilian
    Peeters, Anna
    [J]. PUBLIC HEALTH NUTRITION, 2011, 14 (01) : 119 - 126
  • [43] Pharmacotherapy for obesity in individuals with type 2 diabetes
    Chukir, Tariq
    Shukla, Alpana P.
    Saunders, Katherine H.
    Aronne, Louis J.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (03) : 223 - 231
  • [44] Obesity, Type 2 Diabetes, and Cancer Risk
    Scully, Tiffany
    Ettela, Abora
    LeRoith, Derek
    Gallagher, Emily Jane
    [J]. FRONTIERS IN ONCOLOGY, 2021, 10
  • [45] Intrauterine programming of obesity and type 2 diabetes
    Fernandez-Twinn, Denise S.
    Hjort, Line
    Novakovic, Boris
    Ozanne, Susan E.
    Saffery, Richard
    [J]. DIABETOLOGIA, 2019, 62 (10) : 1789 - 1801
  • [46] Management of obesity in patients with Type 2 diabetes
    Campbell, L
    Rössner, S
    [J]. DIABETIC MEDICINE, 2001, 18 (05) : 345 - 354
  • [47] Obesity and type 2 diabetes: a conflict of interests?
    Williams, G
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 1999, 23 (Suppl 7) : S2 - S4
  • [48] DNA methylation in obesity and type 2 diabetes
    de Mello, Vanessa Derenji Ferreira
    Pulkkinen, Leena
    Lalli, Marianne
    Kolehmainen, Marjukka
    Pihlajamaki, Jussi
    Uusitupa, Matti
    [J]. ANNALS OF MEDICINE, 2014, 46 (03) : 103 - 113
  • [49] High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity
    Denimal, Damien
    Monier, Serge
    Bouillet, Benjamin
    Verges, Bruno
    Duvillard, Laurence
    [J]. METABOLITES, 2023, 13 (02)
  • [50] Current Perspectives for Treating Adolescents with Obesity and Type 2 Diabetes: A Review
    Niechcial, Elzbieta
    Wais, Paulina
    Bajtek, Jan
    Kedzia, Andrzej
    [J]. NUTRIENTS, 2024, 16 (23)